Henry Schein CEO Stanley Bergman to Retire in 2025, Company to Search for Successor

Stanley Bergman, CEO of Henry Schein, to retire by end of 2025 after 35+ years of leadership. Under Bergman's tenure, Henry Schein's revenue grew from $225 million in 1989 to nearly $13 billion in 2024. The company will initiate a formal search for a successor, considering both internal and external candidates.

Henry Schein, Inc. (Nasdaq: HSIC), the global leader in providing health care solutions to office-based dental and medical practitioners, announced today that Stanley M. Bergman will retire as Chief Executive Officer (CEO) at the end of 2025 after 45 years with the company, including over 35 years as CEO. Bergman will continue to serve as Chairman of the Board post-retirement [1].

Under Bergman's tenure, Henry Schein's revenue grew from $225 million in 1989 to nearly $13 billion in 2024, representing an approximate compound annual growth rate (CAGR) of 17.5%. The company's market capitalization grew from $290 million at its initial public offering (IPO) in 1995 to nearly $9 billion today. Additionally, Henry Schein delivered a non-GAAP EPS CAGR of 12.4% over this period [1].

Bergman's leadership saw Henry Schein transform from a small, U.S.-based dental mail order company to a global full-service dental distributor and a leading medical distributor to alternate care sites. He also oversaw the development of the largest provider of global dental practice management software and digital services, and the growth of the dental specialties business, including the 2nd-largest provider of endodontic products and 3rd-largest provider of dental implant and bone regeneration products [1].

The company will initiate a formal search process for Bergman's successor, considering both internal and external candidates. Philip A. Laskawy, Lead Director for Henry Schein, expressed gratitude for Bergman's leadership and confidence in the company's future: "Under Stan’s leadership, Henry Schein has become the global leader in providing dental and medical products and solutions for health care providers in alternate care settings, and we recognize the significant impact he has had on the Company and the entire health care industry" [1].

Bergman thanked Team Schein in a letter, emphasizing the company's purpose-driven mission and its ability to adapt to changing customer needs. He expressed confidence in the company's future and the capabilities of the next generation of leaders, including Andrea Albertini and Tom Popeck, who will continue to advance the BOLD+1 strategic plan [1].

References:
[1] https://investor.henryschein.com/news-releases/news-release-details/stanley-m-bergman-retire-henry-scheins-chief-executive-officer